Overview

Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy

Status:
Completed

Trial end date:
2019-12-17

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the efficacy and safety of intravitreal Aflibercept monotherapy with the efficacy and safety of combined treatment with Aflibercept plus standard photodynamic therapy (PDT) with Verteporfin in age-related macular degeneration (AMD) patients with polypoidal choroidal vasculopathy (PCV).

Phase:

Phase 4

Details

Lead Sponsor:

Association for Innovation and Biomedical Research on Light and Image

Collaborator:

European Vision Institute Clinical Research Network

Treatments:

Aflibercept
Verteporfin